Spinal cord stimulation improves forelimb use in an alpha-synuclein animal model of Parkinson's disease

Spinal Cord Stimulation Exerts Neuroprotective Effects against Experimental Parkinson’s Disease

(2014) Aiko Shinko et al.   PLoS One

Chronic Spinal Cord Electrical Stimulation Protects Against 6-hydroxydopamine Lesions

(2014) Amol P. Yadav et al.   Scientific Reports

Direct and Retrograde Transduction of Nigral Neurons with AAV6, 8, and 9 and Intraneuronal Persistence of Viral Particles

(2013) Karin Löw et al.   HUMAN GENE THERAPY

A patient with Parkinson’s disease benefits from spinal cord stimulation

(2013) Syed Hassan et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity

(2012) Meret Nora Gaugler et al.   ACTA NEUROPATHOLOGICA

Spinal Cord Stimulation for the Treatment of Abnormal Posture and Gait Disorder in Patients With Parkinson's Disease

(2012) Takashi AGARI et al.   NEUROLOGIA MEDICO-CHIRURGICA

Spinal Cord Stimulation for the Treatment of Sensory Symptoms in Advanced Parkinson's Disease

(2012) Andrea Landi et al.   NEUROMODULATION

Impaired neurotransmission caused by overexpression of  -synuclein in nigral dopamine neurons

(2012) M. Lundblad et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons

(2011) M. Decressac et al.   NEUROBIOLOGY OF DISEASE

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia

(2010) Walter J. Schulz-Schaeffer   ACTA NEUROPATHOLOGICA

Functional electrical stimulation helps replenish progenitor cells in the injured spinal cord of adult rats

(2010) Daniel Becker et al.   EXPERIMENTAL NEUROLOGY

Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease

(2010) James B Koprich et al.   Molecular Neurodegeneration

SPINAL CORD STIMULATION FAILED TO RELIEVE AKINESIA OR RESTORE LOCOMOTION IN PARKINSON DISEASE

(2010) W. Thevathasan et al.   NEUROLOGY

Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease

(2009) Julien Dusonchet et al.   NEUROBIOLOGY OF DISEASE

Spinal Cord Stimulation Restores Locomotion in Animal Models of Parkinson's Disease

(2009) R. Fuentes et al.   SCIENCE

Electrical Stimulation of the Cerebral Cortex Exerts Antiapoptotic, Angiogenic, and Anti-Inflammatory Effects in Ischemic Stroke Rats Through Phosphoinositide 3-Kinase/Akt Signaling Pathway

(2009) Tanefumi Baba et al.   STROKE

Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease

(2008) Alim Louis Benabid et al.   LANCET NEUROLOGY